Skip to main content
Premium Trial:

Request an Annual Quote

Anadys Hires Beckman Alumnus; Claire Fraser-Liggett Joins BD Board; BioTrove Replaces CEO; NIGMS Names New Director

BioTrove has appointed Albert Luderer president and CEO.
 
Luderer, who will also become a BioTrove director, comes to the company from Light Sciences, where he was also president and CEO.
 
He has also been president and chief operating officer of BioMérieux and has held senior positions at Dianon Systems and Boehringer Mannheim
 
Luderer has a BA from Drew University and an MS and PhD from Rutgers University.  

 
Anadys Pharmaceuticals has named James Glover chief financial officer and senior vice president of operations, effective immediately.
 
Glover comes to Anadys from Beckman Coulter, where he was chief financial officer.

 
Claire Fraser-Liggett, president and director of the Institute for Genomic Research,will join the board of directors of Becton Dickinson, effective Nov. 20.

 
ProMetic Life Sciences has hired Bruce Pritchard as chief financial officer of its UK affiliate ProMetic BioSciences.
 
Pritchard is a chartered accountant and a member of the Governing Council of the Institute of Chartered Accountants of Scotland.

 
Accelrys has appointed Frank Brown as its chief science officer. Brown comes to Accelrys from Johnson & Johnson, where he was most recently senior research fellow in the office of the chief information officer.
 
Additionally, Accelrys said that Matt Hahn, former chief science and technology officer, will become vice president of platform strategy and technology. A filing with the US Securities and Exchange Commission this week said that Hahn is also resigning as general manager of the company’s SciTegic division on Oct. 15. He will continue to work at the firm on a part-time basis and will earn $10,000 per month.
 
The SEC filing reported that Brown will earn $240,000 per year and will be eligible for a bonus of an additional 40 percent of his annual salary “upon achievement of a combination of corporate and individual performance objectives.”

 
The US Environmental Protection Agency has announced three new bioinformatics hires: Stephen Edwards has joined as systems biologist within the National Health and Environmental Effects Research Laboratory in Research Triangle Park, NC; Richard Judson has joined as bioinformaticist with the EPA’s National Center for Computational Toxicology; and Imran Shah has been appointed computational systems biologist in the NCCT.
 
Edwards most recently served as a senior research scientist and research fellow at Merck’s Rosetta Inpharmatics subsidiary. Judson was senior vice president and chief scientific officer at Genaissance Pharmaceuticals and is the founder of GAMA BioConsulting. Shah joins EPA from Icoria, where he was head of computational systems biology and led the development of the company’s metabolomic biomarker discovery pipeline.  

 
Pharm-Olam International has hired Anthony Orlando as vice president of the global data division, which oversees the company's data management and biostatistics services. Orlando has a background at the Food and Drug Administration’s National Center for Toxicological Research and several contract research organizations.
 
Pharm-Olam has also appointed Louise Pitcher as associate director of clinical data management. Pitcher has worked as a data manager and project manager for the last 10 years for pharmaceutical companies and a CRO.

 
The US Department of Health and Human Services has appointed Robert Kolodner as interim national coordinator for health information technology. Kolodner comes from the Veterans Health Administration, where he was chief health informatics officer.
 
Kolodner assumes a post vacated by David Brailer, who resigned as national coordinator for health IT in April. Brailer currently serves as vice-chair of the American Health Information Community, which is charged with making recommendations to the HHS secretary to facilitate the development and adoption of standards-based health IT.

 
Catherine Lewis has been appointed director of the Division of Cell Biology and Biophysics at the National Institute of General Medical Sciences.
 
Lewis started working at the NIH as a staff fellow in 1983 after earning a PhD in biochemistry from Princeton University in New Jersey. She joined NIGMS six years later, initially serving as a program director in its Division of Genetics and Developmental Biology for grants related to chromosome structure and mechanics.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.